Site-Specific Protein ConjugationSortase A-Mediated LigationControlled Labeling & Biomolecule Assembly
Sortase-mediated conjugation provides a sequence-directed approach for building defined protein conjugates under mild aqueous conditions. Most commonly, Staphylococcus aureus Sortase A recognizes an LPXTG motif engineered into one conjugation partner and catalyzes ligation with a molecule bearing an accessible N-terminal oligoglycine sequence. Because the reaction is directed by compact peptide handles rather than broadly distributed lysine or cysteine residues, it is particularly useful when conjugation position, product homogeneity, and preservation of protein function are important.
BOC Sciences supports sortase-mediated protein labeling and ligation projects from substrate and tag design through reaction optimization, purification, and analytical verification. Our services can be integrated with broader protein conjugation services, protein-peptide conjugation, antibody engineering, and custom bioconjugation workflows to accommodate fluorophores, peptides, proteins, oligonucleotides, affinity tags, polymers, lipids, and other research payloads.
Sortase-mediated ligation is often selected when conventional conjugation chemistry creates too much heterogeneity or places a payload too close to a functional domain. Successful implementation, however, depends on more than adding a sortase recognition sequence. Tag position, terminal accessibility, enzyme variant, payload architecture, reaction equilibrium, purification strategy, and analytical verification must be considered together.
Uncontrolled labeling position: Random amine- or thiol-directed chemistry can modify multiple accessible residues. Sortase-compatible peptide tags provide a defined reaction site when the target biomolecule can be appropriately engineered.
Loss of protein activity: Conjugation near a binding interface or structurally important residue can interfere with function. Terminal or otherwise deliberately positioned sortase handles allow the modification site to be separated from sensitive regions.
Variable conjugation state: Complex mixtures of unmodified and differently substituted products complicate purification and interpretation. A defined sortase tag can simplify product architecture and support controlled conjugation occupancy.
Difficult custom payloads: Fluorophores, biotin, oligonucleotides, peptides, lipids, polymers, and other molecules can be incorporated through appropriately designed oligoglycine- or LPXTG-containing adapters instead of requiring the payload itself to react directly with the protein.
C-Terminal Protein LabelingWe support site-specific C-terminal modification of recombinant proteins containing an accessible LPXTG or commonly used LPETG recognition motif.
Typical deliverables: purified site-specific conjugate, reaction and purification summary, and analytical confirmation selected for the construct.
N-Terminal Protein LabelingProteins exposing a suitable N-terminal glycine or oligoglycine sequence can act as sortase nucleophiles and be coupled to an LPXTG-bearing probe or biomolecule.
Customer value: defined N-terminal functionalization without relying on nonspecific modification of multiple side chains.
Antibody Site LabelingSortase-compatible recombinant antibodies and fragments can be engineered with accessible recognition or nucleophile tags at selected termini for controlled attachment of research payloads.
Projects can be coordinated with our antibody conjugation services when multiple site-specific and conventional strategies are being evaluated.
Protein-Peptide LigationSortase-mediated transpeptidation can connect recombinant proteins with synthetic peptides through defined peptide handles, providing a practical route to semisynthetic constructs.
Typical applications: protein functionalization, semisynthetic protein studies, affinity reagent development, and structure-function research.
Protein-Oligonucleotide LigationOligonucleotide payloads can be equipped with sortase-compatible peptide adapters, allowing a defined protein site to be connected with DNA, RNA, PNA, or related nucleic-acid constructs.
Related projects can be integrated with our protein oligonucleotide conjugation capabilities.
Functional Probe InstallationShort sortase-compatible peptide adapters provide a flexible bridge between a recombinant protein and chemically diverse functional probes.
Customer value: the site-selectivity of enzymatic ligation can be combined with the chemical diversity of secondary conjugation reactions when a direct one-step construct is impractical.
Sortase A is a transpeptidase that recognizes a short peptide sorting motif, typically represented as LPXTG. In a commonly used C-terminal labeling configuration, the recognition motif is positioned near the C-terminus of the target protein while the desired payload is attached to a peptide bearing an N-terminal oligoglycine sequence.
Sortase binds the LPXTG sequence and cleaves the peptide bond between threonine and glycine. The catalytic cysteine of the enzyme forms a transient thioacyl intermediate with the LPXT-containing substrate.
An exposed N-terminal glycine, frequently supplied as an oligoglycine peptide such as GGG-linked payload, approaches the enzyme-bound intermediate and functions as the nucleophile.
Nucleophilic attack resolves the intermediate and forms a new amide bond between the threonine-containing donor and the glycine-containing acceptor, releasing Sortase A.
The resulting construct contains a covalent peptide linkage at the designed position. Excess substrate, sortase enzyme, unmodified protein, and side products are then separated using a purification strategy matched to their physicochemical differences.
The same reaction logic can be reversed for N-terminal protein labeling: the target protein presents an N-terminal glycine nucleophile while the functional reagent carries the LPXTG-containing donor sequence. Engineered sortase variants can also be considered when faster catalysis, altered recognition, or reduced calcium dependence is required.
Sortase-mediated conjugation is defined primarily by peptide recognition rather than by the intrinsic chemical functionality of the final payload. Molecules that cannot themselves act as sortase substrates can often be connected to an oligoglycine- or LPXTG-containing peptide adapter before enzymatic ligation.
| Molecule Type | Typical Sortase Handle | Common Configuration | Key Design Considerations | Potential Output |
| Recombinant Protein | C-terminal LPXTG/LPETG or exposed N-terminal Gly/Glyn | Protein as donor or nucleophile | Terminal accessibility, tag placement, protein stability, spacer length | Site-labeled protein or protein-protein construct |
| Antibody or Fragment | Engineered LPXTG or oligoglycine sequence | Tag positioned on a selected recombinant chain or terminus | Distance from binding regions, chain accessibility, maximum designed occupancy | Defined antibody-probe or antibody-payload conjugate |
| Synthetic Peptide | LPXTG peptide or N-terminal oligoglycine | Peptide serves as donor, acceptor, or payload adapter | Sequence solubility, side-chain compatibility, linker design | Protein-peptide conjugate or semisynthetic construct |
| Oligonucleotide / PNA | GGG-peptide or LPXTG-peptide adapter | Peptide handle installed during or after oligonucleotide preparation | Charge, spacer length, coupling position, chromatographic behavior | Protein-oligonucleotide conjugate |
| Fluorophore / Biotin / Probe | Functionalized oligoglycine or LPXTG peptide | Probe attached to a short synthetic peptide substrate | Dye hydrophobicity, linker length, quenching, probe accessibility | Site-specific labeled protein |
| Polymer / Lipid | Oligoglycine-functionalized adapter | Functional material presented through a peptide linker | Solubility, steric bulk, aggregation, reaction concentration | Protein-polymer or protein-lipid conjugate |
| Surface / Material | Immobilized oligoglycine or LPXTG-containing ligand | Protein-to-surface or material-to-protein ligation | Surface accessibility, linker mobility, nonspecific adsorption | Directionally immobilized protein construct |
Sortase-mediated conjugation is most useful when site definition is a central project requirement and recombinant or synthetic introduction of a short peptide handle is practical. It can offer a particularly useful alternative when modification of naturally occurring lysines or cysteines would produce heterogeneous material or place the payload at functionally undesirable positions.
Use sortase when the experimental question depends on placing a label or payload at a known terminus or engineered position rather than distributing it across multiple reactive residues.
Deliberate tag placement can separate the conjugation junction from binding sites, catalytic domains, interfaces, or other regions that should remain minimally perturbed.
Sortase transpeptidation generates a peptide-bond linkage, making it useful when the project benefits from an amide-based connection between the two partners.
Payloads can be introduced indirectly through short synthetic sortase substrates, separating protein-site recognition from the chemistry used to attach the payload to the adapter.
Sortase may be less suitable when the target cannot be engineered with an accessible recognition handle, when neither terminus can tolerate modification, or when the project requires a direct reaction with an entirely native protein. Reaction reversibility, substrate concentration, payload solubility, enzyme removal, and—in some sortase formats—calcium requirements should also be considered before selecting the method.
No conjugation method is optimal for every molecule. The most appropriate route depends on whether the priority is simplicity, native-protein compatibility, site definition, orthogonality, bond type, or access to an engineered substrate. The matrix below summarizes practical differences for early strategy selection.
| Method | Primary Reactive Handle | Site Control | Key Advantages | Key Considerations | Typical Fit |
| Sortase-Mediated Ligation | LPXTG donor + N-terminal oligoglycine | High when handles are deliberately positioned | Short recognition tags, mild aqueous conditions, defined peptide-bond junction | Requires compatible peptide handles; reaction equilibrium and enzyme variant must be managed | Site-specific protein labeling and biomolecule ligation |
| NHS Ester Coupling | Primary amines, mainly lysines and N-termini | Usually low without special substrate design | Simple workflow and broad reagent availability | Multiple accessible amines can generate positional heterogeneity | General labeling where exact attachment site is not critical |
| Maleimide-Thiol Coupling | Accessible cysteine thiols | Moderate to high when a unique cysteine is available | Efficient thiol-selective chemistry and broad payload availability | Native disulfides and multiple free cysteines can complicate control; linker stability depends on design | Proteins with suitable native or engineered cysteine sites |
| Click Chemistry | Azide/alkyne, tetrazine/TCO, or related orthogonal pairs | High after defined handle installation | Strong chemical orthogonality and broad payload scope | A bioorthogonal handle must first be introduced at the desired position | Modular two-step conjugation and complex payload installation |
| Transglutaminase Conjugation | Compatible glutamine and amine substrates | Dependent on enzyme, substrate accessibility, and tag design | Enzyme-directed coupling under mild conditions | Reactive-site availability and sequence context must be assessed for each protein | Enzymatic protein labeling with appropriate glutamine-containing sites |
Sortase and chemical methods do not need to be mutually exclusive. For example, sortase can first install a single azide, DBCO, or other chemical handle at a defined protein site, followed by a secondary click chemistry reaction with a larger or more complex payload.
We build the workflow around the molecular architecture of the final conjugate rather than applying one reaction recipe to every project. Each stage is used to identify risks that could affect site accessibility, conversion, purification, or downstream function.
We define the target molecule, desired conjugation position, payload, final construct, available material, working buffer, scale, and downstream application. Existing sequences and structural information are reviewed to identify feasible sortase configurations.
The LPXTG/LPETG donor and oligoglycine acceptor are assigned to the appropriate partners. Spacer length, tag accessibility, payload orientation, and any required protease-processing or synthetic adapter strategy are defined before experimental work begins.
Sortase-compatible proteins, peptides, and payload adapters are prepared or reviewed for identity, concentration, solubility, and suitability for ligation. This reduces the risk of optimizing a reaction around a poorly accessible or degraded substrate.
Enzyme variant, substrate ratio, concentration, buffer, calcium conditions where applicable, temperature, and reaction time are adjusted according to substrate behavior. Conversion is monitored rather than assuming that conditions established for one protein will translate directly to another.
The conjugate is separated from sortase, free payload, excess peptide substrate, unreacted target, and potential aggregates using chromatography or other separation methods selected for the specific molecular pair.
Appropriate analytical methods are used to verify identity, conjugation state, purity, aggregation behavior, and relevant functional properties. Final material is supplied with a project-specific analytical and handling summary.
A successful sortase reaction does not by itself establish that a conjugate is suitable for downstream work. The final preparation may still contain free peptide or probe, residual enzyme, unmodified protein, hydrolyzed substrate, or aggregated species. Purification and analytical methods are therefore selected around the size, charge, hydrophobicity, affinity properties, and intended use of the conjugate.
| Development Question | Possible Method | What It Evaluates | Project Value |
| How should free substrate and enzyme be removed? | SEC, affinity purification, IEX, RP-HPLC, ultrafiltration, or buffer exchange as appropriate | Separation of conjugate from unreacted starting materials and enzyme | Produces a cleaner material for downstream analytical or functional studies |
| Did ligation occur at the expected molecular state? | Intact-mass LC-MS, peptide-level MS where appropriate, SDS-PAGE, or electrophoretic analysis | Mass change, conjugation state, and product identity | Distinguishes true ligation from apparent conversion based only on chromatography |
| Is the final preparation sufficiently pure? | Analytical HPLC, SEC, electrophoresis, or related methods | Residual starting material, impurities, fragments, and product distribution | Supports objective comparison between reaction and purification conditions |
| Has aggregation changed? | Analytical SEC and other size-based methods where appropriate | Monomeric state and higher-molecular-weight species | Identifies construct or process conditions that destabilize the protein |
| Is a reporter or chromophore present? | UV-Vis or fluorescence analysis | Optical characteristics and probe incorporation | Useful for fluorescent, chromogenic, or affinity-probe conjugates |
| Was biological function retained? | Binding, activity, interaction, or application-relevant assay where available | Performance relative to the unconjugated or reference material | Shows whether the selected site and linker architecture are suitable for the intended experiment |
The LPXTG motif must be accessible to the enzyme. C-terminal placement is common because the recognition sequence can be introduced with limited disruption to the main protein sequence, but steric context still matters. A flexible spacer may be useful when the terminus is close to the protein surface or another domain.
An N-terminal glycine or oligoglycine must be physically accessible for productive transpeptidation. For recombinant targets intended as the nucleophile, sequence design and expression processing should be planned so that the required glycine is actually exposed rather than masked by an initiator residue, tag, or structured region.
Wild-type and engineered Sortase A variants can differ in catalytic activity, calcium dependence, and accepted substrate motifs. Enzyme choice should therefore be matched to reaction speed, buffer constraints, substrate concentration, and the sequence architecture of the project instead of being treated as interchangeable.
Common S. aureus Sortase A formats can require calcium for efficient activity, whereas engineered calcium-independent variants are also available. Protein stability, downstream assay compatibility, pH, salts, reducing conditions, and metal-ion sensitivity should all be reviewed when selecting the buffer system.
Sortase-mediated transpeptidation can be reversible, and competing hydrolysis may occur. Using an appropriate excess of the nucleophilic partner, controlling substrate concentrations, selecting engineered enzymes, and removing or suppressing reaction byproducts are among the strategies that can be considered when conversion is limited.
Large, hydrophobic, highly charged, or poorly soluble payloads can reduce effective substrate concentration or hinder access to the enzyme. Linker length and composition may therefore be adjusted to separate the oligoglycine or recognition motif from the payload while maintaining the final construct's intended architecture.
We evaluate protein architecture, terminal accessibility, payload position, and intended downstream use before assigning the LPXTG and oligoglycine partners. This helps avoid committing material to a theoretically valid but sterically inaccessible design.
Sortase-compatible peptide adapters can be designed around different payload classes, allowing the enzymatic recognition step to be separated from fluorophore, oligonucleotide, lipid, polymer, or small-molecule chemistry.
Product isolation is considered during construct design rather than after the reaction is complete. Molecular size, affinity tags, charge, payload properties, and enzyme-removal requirements are used to plan a practical purification route.
Analytical methods are selected to answer project-specific questions about conjugation state, identity, aggregation, purity, reporter incorporation, or retained function rather than relying on a single generic readout.
Projects requiring broader chemistry screening can also be coordinated through our custom bioconjugation services so that sortase-mediated ligation can be evaluated alongside alternative site-selective or chemical conjugation strategies.
Whether you are planning a site-specific protein label, an engineered antibody conjugate, a protein-peptide assembly, or a protein-oligonucleotide construct, the most useful starting point is the molecular design of both conjugation partners. Sequence, available termini, target structure, payload properties, desired site, scale, and analytical requirements can all affect the feasibility of a sortase workflow.
Share your target sequence or protein format, proposed payload, desired conjugation position, and downstream research requirements with our scientific team. We can evaluate handle placement, sortase configuration, linker strategy, purification options, and characterization needs before developing a project-specific workflow. Contact us to discuss your sortase-mediated conjugation project.
The most widely used Staphylococcus aureus Sortase A recognizes an LPXTG motif, with LPETG commonly used in engineered conjugation substrates. The enzyme cleaves between threonine and glycine before transferring the LPXT-containing component to an appropriate nucleophile.
An exposed N-terminal glycine sequence acts as the nucleophile that resolves the sortase acyl-enzyme intermediate. Short oligoglycine sequences, commonly several consecutive glycines, are frequently used because they provide an accessible and compact acceptor handle.
In most standard workflows, yes. The target or conjugation partner generally needs an appropriately positioned LPXTG recognition motif or an exposed N-terminal glycine/oligoglycine sequence. If the required handle cannot be introduced without affecting the protein, another conjugation strategy may be more appropriate.
Yes. Recombinant antibodies and antibody fragments can be engineered with sortase-compatible tags at selected termini or chains. Tag location should be chosen with consideration of antigen-binding regions, structure, accessibility, and the intended conjugation stoichiometry. Engineered Sortase A variants have been investigated extensively for antibody labeling.
Sortase-compatible adapters can support attachment of fluorophores, biotin, peptides, proteins, lipids, polymers, oligonucleotides, affinity groups, and other research probes. The payload is commonly connected to a short oligoglycine or LPXTG peptide, allowing sortase to recognize the peptide handle rather than the payload itself.
